Fusion Pharmaceuticals
FUSN
$21.54
Share price
0.51%
Change (1 day)
370.31%
Change (1 year)
Categories
Fusion Pharmaceuticals (FUSN) - P/B ratio
P/B ratio as of May 2024 : 8.19
According to Fusion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 8.19.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Fusion Pharmaceuticals - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.13 | 259.82% |
| 2022-12-31 | 0.8692 | 12.02% |
| 2021-12-31 | 0.7759 | -53.39% |
| 2020-12-31 | 1.66 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.73 | -66.62% | 🇺🇸 USA |